| 闫瑞平,李建彬,安 戈,等.河南省郑州市肿瘤登记地区2022年肺癌流行特征及2016—2022年变化趋势分析[J].肿瘤学杂志,2026,32(7):581-588. |
| 河南省郑州市肿瘤登记地区2022年肺癌流行特征及2016—2022年变化趋势分析 |
| Epidemiological Characteristics of Lung Cancer in Zhengzhou Cancer Registration Areas in 2022 and Epidemiological Trends from 2016 to 2022 |
| 投稿时间：2025-12-18 |
| DOI：10.11735/j.issn.1671-170X.2026.07.B009 |
|
 |
| 中文关键词: 肺肿瘤 发病率 死亡率 趋势分析 河南 |
| 英文关键词:lung neoplasms incidence mortality trend analysis Henan |
| 基金项目: |
|
| 摘要点击次数: 8 |
| 全文下载次数: 0 |
| 中文摘要: |
| 摘 要：［目的］分析郑州市肿瘤登记地区2022年肺癌发病与死亡情况以及2016—2022年变化趋势，为郑州市制定肺癌防治策略提供依据。［方法］ 收集郑州市各肿瘤登记处上报质量合格的肺癌发病与死亡病例资料，计算粗发病率、粗死亡率、中国人口标化（简称中标）发病率、中标死亡率。采用平均年度变化百分比（average annual percent change，AAPC）分析2016—2022年郑州市肿瘤登记地区不同性别、年龄和城乡肺癌发病率和死亡率的变化趋势。［结果］ 2022年郑州市肿瘤登记地区肺癌粗发病率为57.54/10万、中标发病率为36.57/10万，肺癌发病数占全部恶性肿瘤新发病例的20.15%；肺癌粗死亡率为38.70/10万、中标死亡率为22.53/10万，肺癌死亡数占全部恶性肿瘤死亡总数的26.62%。2022年郑州市肿瘤登记地区男性肺癌发病率与死亡率均高于女性，年龄别发病率及死亡率均在45岁后呈现快速上升趋势，并于80～84岁年龄组达到峰值。2016—2022年郑州市肿瘤登记地区肺癌粗发病率与中标发病率整体呈缓慢上升态势，其中女性中标发病率上升趋势尤为显著，而男性中标发病率无明显波动；肺癌粗死亡率呈上升趋势，中标死亡率趋势平稳，其中城市地区中标死亡率呈下降趋势，农村地区中标死亡率无明显波动。［结论］ 2016—2022年郑州市肺癌发病率呈缓慢上升趋势，死亡率未见明显改变。男性及老年人是郑州市肺癌发病与死亡主要人群，而女性与中老年人群发病上升趋势较为突出，应予以重点关注。 |
| 英文摘要: |
| Abstract： ［Objective］ To investigate the incidence and mortality of lung cancer in Zhengzhou cancer registration areas in 2022 and the trends from 2016 to 2022， so as to provide evidence for lung cancer prevention and treatment strategies.［Methods］ Data on lung cancer incidence and death with qualified registration quality were collected from cancer registration offices in Zhengzhou City. Crude incidence， crude mortality， and age-standardized incidence and mortality rates by the Chinese standard population (ASIRC and ASMRC) were calculated. The average annual percent change (AAPC) was used to analyze the trends in lung cancer incidence and mortality from 2016 to 2022 by sex， age， and urban-rural areas. ［Results］ In 2022， the crude incidence rate of lung cancer in Zhengzhou cancer registration areas was 57.54/105， and the ASIRC was 36.57/105. Lung cancer accounted for 20.15% of all newly diagnosed cancer cases. The crude mortality rate was 38.70/105， and the ASMRC was 22.53/105. Lung cancer accounted for 26.62% of all cancer deaths. In 2022， both the incidence and mortality rates of lung cancer were higher in males than in females. Age-specific incidence and mortality rates increased rapidly after age 45 years old and peaked in the age group of 80-84 years old. From 2016 to 2022， both the crude incidence and ASIRC of lung cancer in Zhengzhou showed a slow upward trend. Notably， the ASIRC in females increased significantly， while that in males showed no obvious fluctuation. The crude mortality rate presented an upward trend， whereas the ASMRC remained stable. In urban areas， the ASMRC showed a decreasing trend， while in rural areas it showed no significant change. ［Conclusions］ From 2016 to 2022， the incidence of lung cancer in Zhengzhou slowly increased， while the mortality rate did not change significantly. Lung cancer mainly affects males and the elderly， but the increasing incidence in females and middle-aged and elderly populations deserves special attention. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |